Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without Sitaxentan

Heidelberg University

Status: Completed

Conditions: Hypertension, Pulmonary

Study type: Observational

Funder types: Other

Identifiers

NCT01281371

K344

Details and patient eligibility

About

Due to the withdrawal of Thelin (Sitaxentan) in December 2010 all patients with pulmonary hypertension treated with Sitaxentan need to be switched to an alternative therapy. This study will observe in which way the change of medication - in the clinical routine, without exception in charge of the treating physician - affects clinical and laboratory parameters and patient's quality of life.

Enrollment: 9 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pulmonary hypertension
• Treatment with Sitaxentan

Exclusion criteria

• Inability or unwillingness to give written informed consent